<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-US">
	<id>https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3ARegulatory_equivalence</id>
	<title>Definition:Regulatory equivalence - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3ARegulatory_equivalence"/>
	<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Regulatory_equivalence&amp;action=history"/>
	<updated>2026-06-14T04:39:07Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://www.insurerbrain.com/w/index.php?title=Definition:Regulatory_equivalence&amp;diff=13740&amp;oldid=prev</id>
		<title>PlumBot: Bot: Creating new article from JSON</title>
		<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Regulatory_equivalence&amp;diff=13740&amp;oldid=prev"/>
		<updated>2026-03-13T13:16:48Z</updated>

		<summary type="html">&lt;p&gt;Bot: Creating new article from JSON&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;🔄 &amp;#039;&amp;#039;&amp;#039;Regulatory equivalence&amp;#039;&amp;#039;&amp;#039; is a determination by one jurisdiction that another jurisdiction&amp;#039;s insurance regulatory framework achieves comparable outcomes in areas such as [[Definition:Solvency | solvency]] supervision, [[Definition:Group supervision | group supervision]], and [[Definition:Reinsurance | reinsurance]] oversight — even if the specific rules and mechanisms differ. In insurance, this concept carries significant practical weight: an equivalence finding can determine whether a [[Definition:Reinsurer | reinsurer]] domiciled in one country must post [[Definition:Collateral | collateral]] when transacting business in another, whether an insurance group can rely on its home supervisor rather than meeting duplicative requirements abroad, and whether [[Definition:Insurance carrier | insurers]] face additional [[Definition:Capital requirement | capital]] charges for exposures ceded to foreign counterparties.&lt;br /&gt;
&lt;br /&gt;
⚙️ The most prominent equivalence framework in global insurance operates under the European Union&amp;#039;s [[Definition:Solvency II | Solvency II]] directive, which provides for equivalence assessments in three areas: reinsurance supervision, group solvency calculation, and group supervision of non-EU parent undertakings. [[Definition:European Insurance and Occupational Pensions Authority (EIOPA) | EIOPA]] advises the European Commission on these assessments, evaluating whether a third country&amp;#039;s regime — such as those of Switzerland, Bermuda, or Japan — meets the standards set by Solvency II. Bermuda, for instance, secured equivalence recognition through significant reforms to its own regulatory framework, a strategic move that preserved the island&amp;#039;s competitive position as a global reinsurance hub. Outside Europe, the US-EU Covered Agreement represents a bilateral approach to similar objectives, addressing [[Definition:Reinsurance | reinsurance]] collateral and prudential group supervision without formally adopting the Solvency II equivalence terminology. Similar reciprocal recognition dynamics play out across Asian markets, where regulators in Singapore, Hong Kong, and Japan engage in mutual recognition discussions that affect how cross-border insurance groups structure their operations.&lt;br /&gt;
&lt;br /&gt;
🌍 Equivalence matters far beyond the realm of legal technicality — it shapes the competitive landscape of international insurance markets. When a jurisdiction lacks equivalence recognition, its domiciled insurers and reinsurers face tangible disadvantages: higher collateral requirements, duplicative reporting obligations, and potential barriers to writing cross-border business. Conversely, achieving equivalence status can attract [[Definition:Capital | capital]] and corporate domiciles, as Bermuda&amp;#039;s experience demonstrates. The concept also introduces a geopolitical dimension to insurance regulation, as equivalence decisions can be influenced by broader trade negotiations and diplomatic relations. Brexit brought this into sharp relief, as the United Kingdom&amp;#039;s departure from the EU raised questions about whether UK-based [[Definition:Insurance carrier | insurers]] and [[Definition:Lloyd&amp;#039;s of London | Lloyd&amp;#039;s]] [[Definition:Lloyd&amp;#039;s syndicate | syndicates]] would retain seamless market access — prompting many firms to establish EU subsidiaries as a hedge against uncertain equivalence outcomes.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Related concepts:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
{{Div col|colwidth=20em}}&lt;br /&gt;
* [[Definition:Solvency II]]&lt;br /&gt;
* [[Definition:Regulatory cooperation]]&lt;br /&gt;
* [[Definition:Regulatory harmonization]]&lt;br /&gt;
* [[Definition:Reinsurance]]&lt;br /&gt;
* [[Definition:Group supervision]]&lt;br /&gt;
* [[Definition:Collateral]]&lt;br /&gt;
{{Div col end}}&lt;/div&gt;</summary>
		<author><name>PlumBot</name></author>
	</entry>
</feed>